Your SlideShare is downloading. ×
Orbomed - office based hysteroscopy
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Orbomed - office based hysteroscopy

397
views

Published on

Published in: Health & Medicine

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
397
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. OrbomedEARLY DIAGNOSIS – TIMELY CURE
  • 2. Orbomed teamVitaly Vishnepolsky, MBA CEO Dr. Vadim Sigalov, MDChief Business consultant Chief Medical consultant Ksenia Chagan, MBA Igor Shcherback, PhD Biotech advisor Physics advisor
  • 3. Hysteroscopy: background• Gold standard for detection of intrauterine pathology• Safe and simple procedure for outpatient clinics
  • 4. Hysteroscopy: background (cont.)• From patients’ side pain continues to represent the main limiting factor to a large-scale use of outpatient hysteroscopy
  • 5. Office Based Hysteroscopy(OBH) facts• Only 15% of gynecologists in the United States routinely perform office hysteroscopy to evaluate intrauterine pathology. Reimbursement Equipment
  • 6. The OBH need• Broadening of applications’ list• Cost reduction• Becoming the gold standard for specific operations• Updating of reimbursement policies.
  • 7. Orbomed:Office Based Hysteroscopy product line• Three dimensional scissors• No need for laparoscop reposition• Easier lesion capture in moving media (saline flow)• Ready-for-sending tissue sample post-operationally
  • 8. What is the difference inORBOMED concept?VIDEO>>
  • 9. Advantages of Orbomed• Improved patient’s comfort• Eliminated need for general anesthesia• Shorten interventional procedure• Reduced overall cost
  • 10. Target CustomersPrivate/public gynecological clinics
  • 11. Applications• Polypectomy – 6M of annual visits• Adhesiolysis – 1M of Asherman Syndrome• Biopsy under direct visualization – approx. 50K of new endometrial cancer/year
  • 12. Market potential• Global Uro-Gynecological Surgical Devices Market to Reach US$1.98 Billion by 2015• Global Biopsy devices Market is expected to reach $1.4 Billion by 2018, CAGR 5% from 2011.
  • 13. Orbomed R&D plan• Within 24 months we plan to achieve fully working prototype ready for clinical trials• Planned budget $750K
  • 14. ‫‪Budget‬‬ ‫שיווק‬ ‫שונות‬ ‫%9‬ ‫ציוד‬ ‫%31‬ ‫שכר‬ ‫%3‬ ‫%24‬ ‫קבלני משנה‬ ‫%92‬ ‫חומרים וציוד‬ ‫מתכלה‬ ‫%4‬
  • 15. Thank you